Showing results (71-80 of 104) with videos related to
Sort By:
Pageof 11
Australian and New Zealand Journal of Public Health|July 17, 2017
What Indigenous Australian clients value about primary health care: a systematic review of qualitative evidenceJudith Streak Gomersall, Odette Gibson, Judith Dwyer, et al.Age and Ageing|June 3, 2026
The use of the electronic frailty index to optimise HbA1c targets in older individuals with type 2 diabetesThomas S J Crabtree, Rami Aldafas, Nadeem Qureshi, et al.Pharmacoeconomics - Open|September 15, 2022
Estimating the Economic and Clinical Value of Introducing Ceftazidime/Avibactam into Antimicrobial Practice in Japan: A Dynamic Modelling StudyTetsuya Matsumoto, Akira Yuasa, Ryan Miller, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 24, 2007
Cost-utility analysis when not everyone wants the treatment: modeling split-choice biasRichard Lilford, Alan Girling, David Braunholtz, et al.Cardiovascular Diabetology|January 21, 2009
Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational studyPeter Sharplin, Jason Gordon, John R Peters, et al.Cardiovascular Diabetology|February 18, 2009
Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysisPeter Sharplin, Jason Gordon, John R Peters, et al.BMC Medical Research Methodology|April 12, 2020
Assessing the quality of health research from an Indigenous perspective: the Aboriginal and Torres Strait Islander quality appraisal toolStephen Harfield, Odette Pearson, Kim Morey, et al.Pharmacoeconomics - Open|July 3, 2021
Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision MakingJason Gordon, Angela Stainthorpe, Beverley Jones, et al.European Journal of Gastroenterology & Hepatology|November 7, 2015
The cost-effectiveness of daclatasvir-based regimens for the treatment of hepatitis C virus genotypes 1 and 4 in the UKPhil McEwan, Hayley Bennett, Thomas Ward, et al.Journal of Health Economics and Outcomes Research|October 27, 2021
Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in JapanTetsuya Matsumoto, Oliver Darlington, Ryan Miller, et al.Pageof 11